Document Detail


Hypothesis: Cystic fibrosis carrier geography reflects interactions of tuberculosis and hypertension with vitamin D deficiency, altitude and temperature. Vitamin D deficiency effects and cf carrier advantage.
MedLine Citation:
PMID:  21968085     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Interactions between selective factors (hypertension and tuberculosis) and environmental effects (vitamin D deficiency [VDD], temperature, and altitude) largely explain cystic fibrosis (CF) carrier geography. For VDD sequelae such as hypertension and tuberculosis vulnerability, clinical evidence of carrier protection is supported by indications that decreased CF arylsulfatase B activity suppresses tuberculosis, and that excess CF salt loss decreases blood pressure. A need for salt retention in the tropics selected against CF carriers despite possible advantages against cholera, typhoid, and other factors, but salt retention was less important elsewhere. Increased hypertension with cold selected for carriers with increasing latitude, and with altitude, where hypertensive complications of pregnancy also rise. ΔF508 rates especially seem to follow these parameters, and may be particularly protective against hypertension, while lower rates in Ashkenazi Jews are consistent with a greater role for tuberculosis in this group. This scenario suggests geographical correlations of CF with other genes affecting blood pressure, and significant carrier levels, especially of ΔF508, in mountainous areas of Asia with VDD.
Authors:
Mark Lubinsky
Related Documents :
15757615 - Effect of serum albumin on qrs wave amplitude in patients free of heart disease.
707295 - Effect of afterload reduction on plasma volume during acute heart failure.
1579875 - The fluid content of the human intervertebral disc. comparison between fluid content an...
18379535 - Echocardiographic, electrocardiographic and blood pressure changes induced by icodextri...
2499195 - Pathophysiology of pressure changes during intrauterine transfusion.
1905595 - Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolera...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-1
Journal Detail:
Title:  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society     Volume:  -     ISSN:  1873-5010     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101128966     Medline TA:  J Cyst Fibros     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Simvastatin induces the expression of hemeoxygenase-1 against ischemia-reperfusion injury on the tes...
Next Document:  MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fi...